Natera Inc (NASDAQ: NTRA) stock jumped 2.37% on Monday to $54.79 against a previous-day closing price of $53.52. With 0.96 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.25 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $55.20 whereas the lowest price it dropped to was $53.31. The 52-week range on NTRA shows that it touched its highest point at $63.00 and its lowest point at $34.70 during that stretch. It currently has a 1-year price target of $71.87. Beta for the stock currently stands at 1.29.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NTRA was up-trending over the past week, with a rise of 12.88%, but this was up by 34.42% over a month. Three-month performance surged to 1.93% while six-month performance rose 3.22%. The stock gained 52.83% in the past year, while it has gained 36.40% so far this year. A look at the trailing 12-month EPS for NTRA yields -4.51 with Next year EPS estimates of -2.66. For the next quarter, that number is -0.76. This implies an EPS growth rate of 30.06% for this year and 31.62% for next year.
Float and Shares Shorts:
At present, 111.25 million NTRA shares are outstanding with a float of 109.90 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.67 million, which was 5.61% higher than short shares on Sep 28, 2023. In addition to Dr. Matthew Rabinowitz Ph.D. as the firm’s Co-Founder & Executive Chairman, Mr. Steven Leonard Chapman serves as its CEO & Director.
Through their ownership of 96.09% of NTRA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 52.54% of NTRA, in contrast to 44.94% held by mutual funds. Shares owned by individuals account for 19.37%. As the largest shareholder in NTRA with 8.92% of the stake, The Vanguard Group, Inc. holds 10,223,324 shares worth 10,223,324. A second-largest stockholder of NTRA, Fred Alger Management LLC, holds 6,270,314 shares, controlling over 5.47% of the firm’s shares. JPMorgan Investment Management, I is the third largest shareholder in NTRA, holding 5,634,987 shares or 4.92% stake. With a 3.00% stake in NTRA, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 3,438,136 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.45% of NTRA stock, is the second-largest Mutual Fund holder. It holds 2,808,141 shares valued at 110.84 million. Government Pension Fund – Global holds 2.43% of the stake in NTRA, owning 2,780,427 shares worth 109.74 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NTRA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NTRA analysts setting a high price target of $117.00 and a low target of $37.00, the average target price over the next 12 months is $71.87. Based on these targets, NTRA could surge 113.54% to reach the target high and fall by -32.47% to reach the target low. Reaching the average price target will result in a growth of 31.17% from current levels.
Summary of Insider Activity:
Insiders traded NTRA stock several times over the past three months with 7 Buys and 11 Sells. In these transactions, 10,457 shares were bought while 27,088 shares were sold. The number of buy transactions has increased to 106 while that of sell transactions has risen to 103 over the past year. The total number of shares bought during that period was 530,552 while 386,974 shares were sold.